|
USP31 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.47279990822835E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.12019999999979E-05 |
| Normal-vs-Stage2 |
4.198000E-02 |
| Normal-vs-Stage3 |
5.638200E-04 |
| Normal-vs-Stage4 |
7.408100E-02 |
| Stage1-vs-Stage2 |
7.222200E-01 |
| Stage1-vs-Stage3 |
2.430400E-01 |
| Stage1-vs-Stage4 |
2.400600E-01 |
| Stage2-vs-Stage3 |
1.888810E-01 |
| Stage2-vs-Stage4 |
3.070200E-01 |
| Stage3-vs-Stage4 |
6.966400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11779996370132E-09 |
| Normal-vs-AfricanAmerican |
5.138400E-03 |
| Normal-vs-Asian |
3.270400E-01 |
| Caucasian-vs-AfricanAmerican |
3.453800E-02 |
| Caucasian-vs-Asian |
8.954200E-01 |
| AfricanAmerican-vs-Asian |
6.149600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.26240004297784E-09 |
| Normal-vs-Female |
1.023960E-04 |
| Male-vs-Female |
2.068400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.321900E-03 |
| Normal-vs-Extreme_Weight |
8.628000E-04 |
| Normal-vs-Obese |
2.0047000000023E-06 |
| Normal-vs-Extreme_Obese |
3.617000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.646600E-01 |
| Normal_Weight-vs-Obese |
4.330400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.192800E-01 |
| Extreme_Weight-vs-Obese |
2.191800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.285200E-01 |
| Obese-vs-Extreme_Obese |
1.734810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.116350E-03 |
| Normal-vs-Age(41-60Yrs) |
1.52160000044255E-07 |
| Normal-vs-Age(61-80Yrs) |
4.56120000003057E-06 |
| Normal-vs-Age(81-100Yrs) |
9.908400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.059000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.811500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.119000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.532100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.824300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.767800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.82339999993597E-07 |
| Normal-VS-Type2 PRCC |
9.67219999999935E-05 |
| Normal-VS-KIRP CIMP |
9.196700E-03 |
| Normal-VS-Unclassified PRCC |
6.32549999999288E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.371600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.114000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.557500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.385000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.556400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.049350E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.242100E-03 |
| Normal-vs-N1 |
1.645490E-04 |
| Normal-vs-N2 |
1.214830E-01 |
| N0-vs-N1 |
6.715400E-03 |
| N0-vs-N2 |
1.741590E-01 |
| N1-vs-N2 |
8.354300E-02 |
|
|
